Back to School: How biopharma can reboot drug development. Access exclusive analysis here

PT-141: Phase IIb

PTN completed enrollment of 270 patients in a U.S. Phase

Read the full 102 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE